Gary E. Pakes
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 21
- HIV/AIDS Research and Interventions 7
- Virology 10
- HIV Research and Treatment 10
- Co-authors
- G.S. Avery (10 shared papers)Rex N. Brogden (10 shared papers)R.C. Heel (10 shared papers)T.M. Speight (10 shared papers)Geoffrey J. Yuen (3 shared papers)Katy H. P. Moore (5 shared papers)Mark Johnson (1 shared paper)Alan Bye (1 shared paper)
- Journals
- Drugs (10 papers)HIV/AIDS - Research and Palliative Care (3 papers)AIDS Research and Human Retroviruses (3 papers)The Journal of Clinical Pharmacology (3 papers)Advances in Therapy (2 papers)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Gary E. Pakes
49 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 126
- Virology 270
- Infectious Diseases 671
- Emergency Medicine 188
- Pharmaceutical Science 88
- Pharmacology 211
Countries citing papers authored by Gary E. Pakes
This map shows the geographic impact of Gary E. Pakes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary E. Pakes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary E. Pakes more than expected).
Fields of papers citing papers by Gary E. Pakes
This network shows the impact of papers produced by Gary E. Pakes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary E. Pakes. The network helps show where Gary E. Pakes may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary E. Pakes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 226 | |
| 2 | 1980 | 213 | |
| 3 | 1980 | 150 | |
| 4 | 1980 | 140 | |
| 5 | 1999 | 115 | |
| 6 | 2008 | 112 | |
| 7 | 1981 | 112 | |
| 8 | 1980 | 108 | |
| 9 | 1980 | 87 | |
| 10 | 2008 | 79 | |
| 11 | 2006 | 60 | |
| 12 | 1980 | 55 | |
| 13 | 2001 | 50 | |
| 14 | 2001 | 48 | |
| 15 | 1979 | 43 | |
| 16 | 1999 | 41 | |
| 17 | 1980 | 38 | |
| 18 | 1999 | 37 | |
| 19 | 2005 | 31 | |
| 20 | 1980 | 31 |
About Gary E. Pakes
Gary E. Pakes is a scholar working on Infectious Diseases, Virology, Pharmacology, Emergency Medicine and Epidemiology, having authored 49 papers that have together received 2.0k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (21 papers), HIV Research and Treatment (10 papers), HIV/AIDS Research and Interventions (7 papers), HIV-related health complications and treatments (6 papers), Inflammatory mediators and NSAID effects (3 papers), Academic Writing and Publishing (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). The work is most often cited by research in Virology (270 citations), Infectious Diseases (671 citations), Emergency Medicine (188 citations), Pharmaceutical Science (88 citations) and Pharmacology (211 citations). Gary E. Pakes has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include G.S. Avery, Rex N. Brogden, R.C. Heel, T.M. Speight, Geoffrey J. Yuen, Katy H. P. Moore, Mark Johnson, Alan Bye, Steve Weller and Keith A. Pappa. Their work appears in journals such as Drugs, HIV/AIDS - Research and Palliative Care, AIDS Research and Human Retroviruses, The Journal of Clinical Pharmacology and Advances in Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.